Iconic Labs PLC (LSE: ICON) has announced the conversion of one Convertible Note into 505,050 new ordinary shares following a valid Conversion Notice dated 5 November 2026. The conversion was executed at a price of GBP 0.0099 per share, representing an aggregate principal amount of £5,000. Application has been made for the new shares to be admitted to trading on the Main Market of the London Stock Exchange on or around 12 November 2026. The disclosure increases the company's total issued ordinary share capital to 18,920,252 shares, a figure investors must now use when assessing their notification obligations under FCA transparency rules.

Key Points

  • Iconic Labs PLC (LSE: ICON) — a company listed on the Main Market of the London Stock Exchange
  • One Convertible Note with a principal value of £5,000 has been converted into 505,050 ordinary shares at GBP 0.0099 per share
  • New shares are expected to be admitted to trading on or around 12 November 2026 and rank pari passu with existing ordinary shares
  • Investors should monitor total issued share capital, now standing at 18,920,252 ordinary shares, for FCA disclosure threshold calculations

Conversion Terms: £5,000 Note Exchanged at GBP 0.0099 Per Share

The Conversion Notice, dated 5 November 2026, triggered the exchange of a single Convertible Note at an aggregate principal amount of £5,000 into 505,050 ordinary shares of £0.0001 each. The conversion price of GBP 0.0099 per share was specified in the notice. The announcement states that application is being made for these new shares to be admitted to trading on the Main Market of the London Stock Exchange, with admission expected on or around 12 November 2026. The newly issued shares carry the same rights as existing ordinary shares, ranking pari passu in all respects.

Iconic Labs' Total Issued Share Capital Rises to 18,920,252 Ordinary Shares

Following the allotment of 505,050 new ordinary shares, Iconic Labs' total issued ordinary share capital now stands at 18,920,252 shares. The company's announcement confirms this figure also represents the total number of voting rights in the company. Under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules, shareholders are required to use this denominator of 18,920,252 to determine whether their interest in the company has crossed a threshold requiring formal notification to the FCA and to Iconic Labs itself.

Inside Information Disclosure and Regulatory Obligations Under UK MAR

Iconic Labs has confirmed that this announcement constitutes inside information as defined under Article 7 of the Market Abuse Regulation, retained as part of UK domestic law through the European Union (Withdrawal) Act 2018. The company has disclosed the information in accordance with its obligations under Article 17 of UK MAR. Investors monitoring dilution risk should note that convertible note structures can result in incremental share issuances over time, and each conversion event will adjust the denominator used for FCA transparency threshold calculations. AlbR Capital Limited acts as the company's adviser, with Yellow Jersey PR handling media enquiries.